Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416615 (4-((4-amino-3-(2-cyclopropoxyquinolin-6-yl)-1H-pyr...) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.700 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416611 (4-((4-amino-3-(6-cyclopropoxynaphthalen-2-yl)-1H-p...) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.700 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416551 (US10307425, Example 17 | US10632122, Example 17) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.800 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416560 (US10307425, Example 26 | US10632122, Example 26) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.900 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416572 (3-(2-cyclopropoxyquinolin-6-yl)-1-(piperidin-4-ylm...) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416558 (US10307425, Example 24 | US10632122, Example 24) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid PDB UniChem | PDB US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416552 (US10307425, Example 18 | US10632122, Example 18) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.20 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416565 (3-(4-amino-3-(6-ethoxynaphthalen-2-yl)-1H-pyrazolo...) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.20 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416553 (US10307425, Example 19 | US10632122, Example 19) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.30 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416613 (4-((4-amino-3-(2-ethoxyquinolin-6-yl)-1H-pyrazolo[...) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.30 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416577 (1-(piperidin-4-ylmethyl)-3-(2-(2,2,2-trifluoroetho...) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.40 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416538 (US10307425, Example 4 | US10632122, Example 4) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.5 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416619 (4-((4-amino-3-(2-ethoxyquinolin-6-yl)-1H-pyrazolo[...) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.5 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416537 (US10307425, Example 3 | US10632122, Example 3) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.60 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416570 (3-(4-amino-3-(2-ethoxyquinolin-6-yl)-1H-pyrazolo[3...) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.70 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416569 (1-isobutyl-3-(6-(2-methoxyethoxy)naphthalen-2-yl)-...) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.70 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416556 (US10307425, Example 22 | US10632122, Example 22) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.80 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416554 (US10307425, Example 20 | US10632122, Example 20) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.80 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM50389717 (CHEMBL2070085 | US10307425, Example 107 | US106321...) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.90 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416627 (3-(6-(difluoromethoxy)naphthalen-2-yl)-1-(piperidi...) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.90 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416576 (1-isobutyl-3-(2-(2,2,2-trifluoroethoxy)quinolin-6-...) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416637 (3-(2-ethoxyquinolin-6-yl)-1-isopropyl-1H-pyrazolo[...) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416559 (US10307425, Example 25 | US10632122, Example 25) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid PDB UniChem | PDB US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416541 (US10307425, Example 7 | US10632122, Example 7) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.10 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM50389718 (CHEMBL2070086 | US10307425, Example 108 | US106321...) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.20 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416550 (US10307425, Example 16 | US10632122, Example 16) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.20 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416573 (1-(azetidin-3-ylmethyl)-3-(2-cyclopropoxyquinolin-...) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.30 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416555 (US10307425, Example 21 | US10632122, Example 21) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.40 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416633 (4-((4-amino-3-(6-(difluoromethoxy)naphthalen-2-yl)...) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.5 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416535 (US10307425, Example 1 | US10632122, Example 1) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.5 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416563 (3-(6-cyclobutoxynaphthalen-2-yl)-1-((tetrahydro-2H...) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.60 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416630 (3-((4-amino-3-(6-ethoxynaphthalen-2-yl)-1H-pyrazol...) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.60 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM50389719 (CHEMBL2070087 | US10307425, Example 109 | US106321...) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.70 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416607 (4-((4-amino-3-(6-ethoxynaphthalen-2-yl)-1H-pyrazol...) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.70 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416574 (3-(2-cyclopropoxyquinolin-6-yl)-1-((1-methylazetid...) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.80 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416598 ((3-((4-amino-3-(6-cyclopropoxynaphthalen-2-yl)-1H-...) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.90 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416582 (3-(6-ethoxynaphthalen-2-yl)-1-((3-methyloxetan-3-y...) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.90 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416626 (3-((4-amino-3-(2-ethoxyquinolin-6-yl)-1H-pyrazolo[...) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.90 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416634 (3-((4-amino-3-(2-cyclopropoxyquinolin-6-yl)-1H-pyr...) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM50389720 (CHEMBL2070088 | US10307425, Example 110 | US106321...) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416648 (1-((6-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrim...) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416588 (1-(4-amino-5-(2-cyclopropoxyquinolin-6-yl)-7H-pyrr...) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.20 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416557 (US10307425, Example 23 | US10632122, Example 23) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.30 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM50250014 (CHEMBL2324597 | US11208411, Compound 3CIB-PP1) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid PDB UniChem Patents Similars | PDB US Patent | n/a | n/a | 3.38 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Full length CDPK1 was PCR amplified from a T. gondii RH cDNA library generated using the SMART cDNA synthesis kit (Clontech). The primers contained r... | Citation and Details BindingDB Entry DOI: 10.7270/Q21G0QGQ | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM50389684 (CHEMBL2070051 | US10307425, Example 119 | US106321...) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.40 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416616 (4-((4-amino-3-(6-cyclopropoxynaphthalen-2-yl)-1H-p...) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.5 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416597 ((3-((4-amino-3-(2-cyclopropoxyquinolin-6-yl)-1H-py...) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.60 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416571 (3-(2-(2-methoxyethoxy)quinolin-6-yl)-1-neopentyl-1...) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.80 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416624 (3-((4-amino-3-(6-cyclopropoxynaphthalen-2-yl)-1H-p...) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.80 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CAM kinase, CDPK family TgCDPK1 (Toxoplasma gondii (strain ATCC 50861 / VEG)) | BDBM416544 (US10307425, Example 10 | US10632122, Example 10) | PDB MMDB KEGG UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington US Patent | Assay Description Inhibitors were evaluated in triplicate in eight-point dilutions (3-fold dilutions) during the enzymatic reactions. TgCDPK1 enzymatic inhibition was ... | US Patent US10307425 (2019) BindingDB Entry DOI: 10.7270/Q2862JT9 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 152 total ) | Next | Last >> |